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The habenula is a small, bilateral brain structure located at the dorsal end of the
diencephalon. This structure sends projections to the dopaminergic striatum and receives
inputs from the limbic forebrain, making the habenula a unique modulator of cross-talk
between these brain regions. Despite strong interest in the habenula during the seventies
and eighties (Herkenham and Nauta, 1977; Beckstead, 1979; Beckstead et al., 1979;
Herkenham and Nauta, 1979; Caldecott-Hazard et al., 1988), interest waned due to lack
of a clearly identifiable functional role. Following Matsumoto and Hikosaka’s seminal work
on the lateral habenula as a predictor of negative reward in monkeys, the habenula has
undergone a resurgence of scientific interest. Matsumoto and Hikosaka demonstrated
an increase in habenular neuron firing when monkeys did not receive an expected juice
reward (Matsumoto and Hikosaka, 2007). Studies have shown that increased habenular
activity inactivates dopaminergic cells in the Rostromedial Tegmental Nucleus (RMTg)
through GABAergic mechanisms (Jhou et al., 2009a,b). Additional studies link habenular
activity to the regulation of serotonin and norepinephrine, suggesting the habenula
modulates multiple brain systems (Strecker and Rosengren, 1989; Amat et al., 2001).
These discoveries ushered in a series of new studies that have refocused attention on
the lateral habenula and the importance of this small brain structure (Bianco and Wilson,
2009; Jhou et al., 2009a; Matsumoto and Hikosaka, 2009; Sartorius et al., 2010; Savitz
et al., 2011). Recently, Geisler and Trimble reviewed this renewed interest in: The Lateral
Habenula: No Longer Neglected (Geisler and Trimble, 2008). While the lateral habenula
(LHb) has been extensively studied, the anatomically and histochemically distinct medial
habenula (MHb) remains largely understudied. This short review argues that the MHb is
functionally important and should be studied more aggressively.
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THE MEDIAL HABENULA
The habenula (Latin for “little rein,” based on its shape) is a small,
complex, and evolutionarily conserved structure. The habenu-
lar complex on the dorsal diencephalon is surrounded by the
third ventricle and includes the medial habenula (MHb) and
lateral habenula (LHb) (Figure 1). Both structures contain sub-
nuclei, although structure-function relationships within these
subdivisions have not been well characterized beyond localized
expression of different neurotransmitter genes (Andres et al.,
1999; Geisler et al., 2003). Gene expression in the MHb and
LHb is very different, suggesting different functions (Figure 1).
While the resurgence in habenula research in the last few years
has focused primarily on the LHb, studies show that the MHb
plays an important role in stress (Lecourtier et al., 2004; Mathuru
and Jesuthasan, 2013), depression (Shumake et al., 2003), mem-
ory (Kobayashi et al., 2013), and nicotine withdrawal (Salas et al.,
2009; Fowler et al., 2011; Frahm et al., 2011).
Abbreviations: MHb, Medial Habenula; LHb, Lateral Habenula; VTA, Ventral
Tegmental Area; IPN, Interpeduncular Nucleus; FR, Fasciculus Retroflexus; Ach,
Acetylcholine; Glu, Glutamate; nAChR, Nicotinic Acetylcholine Receptor; RMTg,
Rostromedial Tegmental Nucleus; TSN, Triangular Septal Nucleus; DA, Dopamine;
MDD, Major Depressive Disorder; TeTXlc, Light Chain Tetanus Toxin.
AFFERENTS AND RECEPTORS
The MHb primarily receives inputs via the stria medullaris,
a white matter pathway originating in the limbic system
(Herkenham and Nauta, 1977; Qin and Luo, 2009). The most
prominent MHb inputs are the triangular septal nucleus (TSN)
and septofimbral nucleus (Herkenham and Nauta, 1977). Most
posterior septum afferents terminate as cholinergic or sub-
stance P neurons, although inputs from the TSN may release
glutamate (Glu) onto the habenula along with its ATP co-
transmitter (Contestabile and Fonnum, 1983; Contestabile et al.,
1987; Sperlagh et al., 1998; Lecourtier and Kelly, 2007; Qin
and Luo, 2009)Many monoaminergic MHb inputs have been
reported, including from the stem of the Ventral Tegmental Area
(VTA), the mesencephalic raphe in the midbrain (Herkenham
and Nauta, 1977), dopaminergic inputs from the interfascicular
nucleus of VTA (Phillipson and Pycock, 1982), and noradrener-
gic inputs from the locus coeruleus and superior cervical ganglion
(Gottesfeld, 1983). The MHb also receives GABAergic input from
the Nucleus of Diagonal band in the basal forebrain and the
medial septum (Qin and Luo, 2009). Interestingly, the MHb
contains one of the highest concentrations of GABA(B) recep-
tors in the brain, suggesting the presence of strong inhibitory
inputs (Bischoff et al., 1999; Durkin et al., 1999; Charles et al.,
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FIGURE 1 | The Medial habenula. (A) Mouse coronal brain section at the
level of the medial habenula, stained with Nissl. Medial (MHb) and lateral
(LHb) are indicated. (B,C) Pattern of general genetic co-expression in the
mouse brain using the MHb (B) or the LHb (C) as seeds. Note that the
expression patterns are completely different. All figures from the Allen
Brain Atlas (Lein et al., 2007).
2001; Wang et al., 2006). The MHb is also widely known for its
abundance of nicotinic acetylcholine receptors (nAChRs). It is
estimated that 90-100% of the neurons in the MHb express α3,
α4, α5, β2, and/or β4 nA ChR subunits (Sheffield et al., 2000).
EFFERENTS AND NEUROTRANSMITTERS
The MHb projects to the Interpeduncular Nucleus (IPN) via the
internal portion of the fasciculus retroflexus (FR) (Herkenham
and Nauta, 1979; Carlson et al., 2001) while the external por-
tion of the FR axon bundle connects the LHb to the RMTg
(Ellison, 2002). It has also been suggested that the MHb projects
to the pineal gland and other midbrain structures (Rønnekleiv
and Møller, 1979). The MHb projections to the IPN are par-
ticularly noteworthy because they contain three major output
neurotransmitters: acetylcholine (Ach), Substance P, and Glu.
Unlike the LHb, which diffusely expresses neurotransmitters
across sub-nuclei, neurotransmitter expression in the MHb is
highly localized. The superior MHb is glutamatergic and also
expresses Interleukin-18 (IL-18); the dorsal-central MHb is both
glutamatergic and substance P-ergic; and the inferior, ventral-
center and lateral MHb are both cholinergic and glutamatergic
(Aizawa et al., 2012). The restricted expression of these neu-
rotransmitters to habenular sub-fields suggests a greater degree
of functional specialization in the MHb than in the LHb. This
specialization likely extends to projections from specific MHb
sub-nuclei to downstream targets. It is likely that Glu projec-
tions from the MHb terminate in the IPN based on the high
levels of cholinergic pre-synaptic markers and cholinergic recep-
tors in this brain area (Hokfelt et al., 1975; Claudio Cuello et al.,
1978; Brown et al., 1983; McGehee et al., 1995; Qin and Luo,
2009; Ren et al., 2011). The ACh and Substance P containing FR
fibers project from the MHb through the IPN and then termi-
nate in the VTA, possibly through an indirect pathway (Claudio
Cuello et al., 1978; Balcita-Pedicino et al., 2011). Additional MHb
projections continue beyond the IPN to the raphe nuclei in the
brainstem. In turn, the raphe nuclei regulate serotonin levels
throughout the brain (Groenewegen et al., 1986). Lastly, there
is evidence of boutons en passant from the MHb to the LHb,
but not from the LHb to the MHb (Kim and Chang, 2005).
This directional connection suggests that the MHb may regulate
LHb activity, while the LHb probably does not directly influence
activity in the MHb. This needs to be further explored because
the possible functional implications are important: it is possi-
ble that the MHb is one more input for the LHb, thus drugs
and events that alter MHb activity would indirectly impinge
on dopamine levels in the striatum. Although the function of
the MHb is not likely to only provide input to the LHb, it is
possible that at least some of the roles of the MHb in drug addic-
tion are mediated by the connectivity with the LHb. However,
the MHb to IPN connection is so prominent that other func-
tions for the MHb that are not mediated by the LHb are likely
important.
LESION STUDIES
Given their small size and close proximity, electrically- or
chemically-induced habenular lesions frequently affect both the
MHb and LHb. Thus, it is often difficult to distinguish MHb and
LHb function based on lesion data alone. In rodent studies, whole
habenular lesions have been shown to cause cognitive impair-
ment (spatial learning and memory), attention deficits, hyper-
reactivity to stress, and schizophrenic-like symptoms (impaired
performance in spatial memory) on the Morris Water Maze.
These results prompted researchers to speculate about the pos-
sible involvement of the habenula in schizophrenia (Lecourtier
et al., 2004). Lee and Goto (2011) demonstrated similar results
after pharmacologically lesioning the MHb and LHb in rodents
with ibotenic acid. Developmental disruption of prefrontal cor-
tex volume, decreased dopamine (DA) receptor expression, and
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decreased DA transporter expression were observed and mani-
fested through deficits in impulsivity, attention, and locomotion,
respectively, suggesting the habenula’s potential involvement in
ADHD. These deficits were also seen when ibotenic acid was
injected in the habenula and induced MHb-specific lesions, sug-
gesting the MHb is responsible for the observed phenotypes
rather than the “whole habenula” (Lee and Goto, 2011). When
Gpr151 expressing neurons in the MHb were selectively elimi-
nated using Cre-mediated expression of Eno2-STOP-DTA, there
was a significant decrease of ACh in the IPN and a wide range of
behavioral effects including: hyperactivity during the early night
period, maladaptation to new environments, impulsive and com-
pulsive behavior, delay and effort aversion in decision-making,
deficits in spatial memory, reduced flexibility in complex learn-
ing paradigms, and lack of susceptibility to nicotine (Kobayashi
et al., 2013). These findings suggest that neurons in the MHb are
directly responsible for these behaviors and for regulating down-
stream expression of ACh. The development of tools andmethods
for selectively lesioning the MHb and MHb sub-fields opens the
door to future avenues for studying the role of MHb in cognitive
and behavioral processes.
MOOD AND ANXIETY DISORDERS
While the link between LHb hyperactivity and major depression
disorder (MDD) receives the most scientific attention (Sartorius
et al., 2010; Li Piriz et al., 2011), elevated activity in the MHb and
IPN have also been linked to depression (Caldecott-Hazard et al.,
1988). In rat studies of learned helplessness, a model of human
MDD, researchers observed increased metabolic activity in the
MHb, LHb, and IPN along with decreased metabolic activity in
the VTA, basal ganglia, and amygdala (Shumake et al., 2003).
These effects may be attributed to restricted brain expression
of IL-18, a proinflammatory cytokine, in the superior subnu-
cleus of the MHb (Sugama et al., 2002). Noradrenergic inputs
into the MHb may trigger IL-18 (Aizawa et al., 2012). IL-18 is
known to promote sleep in rabbits and rats (Kubota et al., 2001)
and stimulates stress-induced immune responses that cause brain
inflammation (Sugama et al., 2002). This stress response could
lead to depression and other mood disorders (Dantzer et al.,
2008). The inflammatory response caused by IL-18may also cause
degradation of the FR white matter pathway between the MHb
and IPN (Felderhoff-Mueser et al., 2005). These white matter dis-
ruptions may play a role in schizophrenia (Sandyk, 1991; Ellison,
1994; Kelly, 1998).
The MHb may also play an important role in anxiety and
fear (Yamaguchi et al., 2013). Severing the parallel pathways
between the MHb and the TSN and bed nucleus of the ante-
rior commissure in mice results in reduced anxiety and amplified
fear responses (Yamaguchi et al., 2013). In zebrafish, nitroreduc-
tase lesions of the MHb increased fear-induced freezing behavior
when electric shocks were paired with a red light compared to
non-lesioned control fish (Agetsuma et al., 2010). Similarly, when
light chain tetanus toxin (TeTXlc) expressing larval zebrafish were
trained to swim away from a red light that predicted shock,
fish with tetanus toxin-induced MHb lesions developed freezing
behavior gradually while control fish did not develop freezing
behavior (Lee et al., 2010). Mathuru and Jesuthasan buttressed
these findings in a fear-inducing overshadow (simulation of
a natural stressor—a predator) experiment. TeTXlc-expressing
zebrafish with MHb lesions exhibited increased fear intensity as
measured by increased time spent in the bottom quarter of the
fish tank and increased episodes of pauses and slow swimming
(Mathuru and Jesuthasan, 2013). Understanding the relationship
between the MHb and both the LHb and IPN may reveal insight
into depression and mood disorders and should be a future area
of study.
THE RE-BIRTH OF THE MEDIAL HABENULA: NICOTINE
STUDIES
One of the most striking features of the MHb is the high level
of the nAChR expression (McCormick and Prince, 1987; Quick
et al., 1999). Historically, α4, α7, and β2 subunit-containing
nAChRs in the VTA, striatum, cortex, and hippocampus have
been the focus of nicotinic research to the known role these
structures play in nicotine addiction and to the high levels
of nAChR expression in these areas (Picciotto et al., 1998;
Franceschini et al., 2002; Maskos et al., 2005). The creation
of nAChR gene knock-out (KO) mice has drawn attention to
other nAChR subunits and to structures with high levels of
other nAChR subunits, such as α3, b4 and α5 in the MHb or
IPN (Cui et al., 2003; Salas et al., 2003, 2004a, 2009; Kedmi
et al., 2004). Several lines of nAChR subunit KO mice were
created and extensively characterized. The α3 and β4 subunits
were initially created to explore their importance in peripheral
nervous system function. In fact, both α3 KO and β2/β4 dou-
ble KO mice die within days of birth due to peripheral defects
such as growth deficiency, megacystis, and mydriasis (Xu et al.,
1999a,b). Historically, β2 was considered the “addiction subunit,”
since mice lacking this subunit did not self-administer nicotine
(Picciotto et al., 1998; Picciotto and Corrigall, 2002). However,
the α5 and β4 subunits were shown to be necessary for nicotine-
induced seizures and hypolocomotion, and somatic symptoms of
nicotine withdrawal (Salas et al., 2004a,b, 2009). Heterozygous
α3 mice also have shown decreased nicotine-induced seizures
while β2 KO mice showed normal somatic withdrawal, indi-
cating subunit-specific related behaviors (Salas et al., 2004a).
The α4 subunit was also identified as sufficient for reward,
tolerance, and sensitization behaviors in mice (Tapper et al.,
2004).
Symptoms of nicotine withdrawal can be induced in mice
using chronic nicotine treatment followed by either sudden treat-
ment cessation or mecamylamine (a broad spectrum nAChR
antagonist) injection (De Biasi and Salas, 2008). Using this
methodology, a role for the α2, α5, and β4 subunits in the MHb
and IPN during nicotine withdrawal was determined (Salas et al.,
2004a, 2009). The α5 subunit is expressed in the MHb and high
doses of nicotine are shown to stimulate the MHb-IPN tract and
inhibit nicotine consumption. However, mice lacking the nAChR
α5 subunit have exhibited decreased MHb to IPN input and lack
nicotine-induced inhibition of the brain’s reward system (Fowler
et al., 2011). Similarly, elevated expression of the nAChR β4 sub-
unit increases nicotine aversion in mice by enhancing activity of
the MHb to the IPN. However, nicotine aversion is reversed by
increasing α5 expression in the MHb (Frahm et al., 2011). Thus
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we can conclude that a critical balance between α5 and β4 expres-
sion may be important for habenular activity, and for nicotine
consumption. Disruption of this balance in smokers may lead to
high levels of nicotine use which may, in turn, selectively damage
the FR.
Another avenue of MHb research utilizes pharmacological
agents that specifically target the habenula. The African shrub
Tabermanthe iboga contains ibogaine, an alkaloid with halluci-
natory properties. ibogaine has a number of anti-addictive prop-
erties and has been shown to block rodent self-administration
of cocaine (Cappendijk and Dzoljic, 1993), alcohol (Rezvani
et al., 1995), and morphine (Glick et al., 1991). While ibo-
gaine is banned in the United States and many other countries,
a derivative of ibogaine (18-Methoxycoronaridine, 18MC) has
been used to reduce the effects of nicotine, cocaine, alcohol,
and amphetamine without major side effects (Glick et al., 2006;
Taraschenko et al., 2007). 18MC is an antagonist that targets the
highly-expressed β4 subunit in the MHb and IPN (Glick et al.,
2006). Taken together, these results suggest that nAChRs in the
MHb are involved in multiple forms of addiction, including:
nicotine, cocaine, methamphetamine, and alcohol. Pre-treatment
with 18MC in rats may also block the observed increase of
DA in the nucleus accumbens following acute nicotine treat-
ment (Nisell et al., 1994; McCallum et al., 2012). Thus the MHb
may also be functionally connected to DA release in the nucleus
accumbens.
HUMAN STUDIES
A few human neuroimaging studies have defined habenular
activity (Ullsperger and von Cramon, 2003; Salas et al., 2010).
However, the resolution of current MRI techniques does not seem
to allow for the separation of signals from the MHb and LHb.
Using 7T scanners (while most research is done in 3T scanners)
it has been shown that the human medial and the LHb can be
distinguished anatomically in ex-vivo brains, but not functionally
in vivo (Strotmann et al., 2013a,b).
CONCLUSION
This review addresses the importance of the MHb in regulating
behavior and the involvement of this structure in multiple neu-
ropathologies and addiction. A growing literature suggests that
the MHb plays an important role in mood disorders, anxiety,
stress, memory, and nicotine withdrawal as well as in cocaine,
methamphetamine, and alcohol addiction. We strongly suggest
that the MHb should no longer be neglected.
ACKNOWLEDGMENTS
This work was supported byNIH grants DA026539 andDA09167.
Additional funding and support was provided by the McNair
Medical Institute and the Brain and Behavior Foundation. We
acknowledge the support of the Diana Helis Henry Medical
Research Foundation through its direct engagement in the
continuous active conduct of medical research in conjunction
with the Baylor College of Medicine Menninger Clinic, the
Department of Psychiatry, and the Duncan Cancer Center. The
authors would like to thank Eduardo Aramayo, for his assistance.
REFERENCES
Agetsuma, M., Aizawa, H., Aoki, T., Nakayama, R., Takahoko, M., Goto, M., et al.
(2010). The habenula is crucial for experience-dependent modification of fear
responses in zebrafish. Nat. Neurosci. 13, 1354–1356. doi: 10.1038/nn.2654
Aizawa, H., Kobayashi, M., Tanaka, S., Fukai, T., and Okamoto, H. (2012).
Molecular characterization of the subnuclei in rat habenula. J. Comp. Neurol.
520, 4051–4066. doi: 10.1002/cne.23167
Amat, J., Sparks, P., Matus-Amat, P., Griggs, J., Watkins, L., and Maier, S. (2001).
The role of the habenular complex in the elevation of dorsal raphe nucleus sero-
tonin and the changes in the behavioral responses produced by uncontrollable
stress. Brain Res. 917, 118–126. doi: 10.1016/S0006-8993(01)02934-1
Andres, K. H., Düring, M. V., and Veh, R. W. (1999). Subnuclear organiza-
tion of the rat habenular complexes. J. Comp. Neurol. 407, 130–150. doi:
10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8
Balcita-Pedicino, J. J., Omelchenko, N., Bell, R., and Sesack, S. R. (2011). The
inhibitory influence of the lateral habenula on midbrain dopamine cells: ultra-
structural evidence for indirect mediation via the rostromedial mesopontine
tegmental nucleus. J. Comp. Neurol. 519, 1143–1164. doi: 10.1002/cne.22561
Beckstead, R. M. (1979). An autoradiographic examination of corticocortical and
subcortical projections of the mediodorsal−projection (prefrontal) cortex in
the rat. J. Comp. Neurol. 184, 43–62. doi: 10.1002/cne.901840104
Beckstead, R. M., Domesick, V. B., and Nauta, W. J. (1979). Efferent connections
of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175,
191–217. doi: 10.1016/0006-8993(79)91001-1
Bianco, I. H., and Wilson, S. W. (2009). The habenular nuclei: a conserved asym-
metric relay station in the vertebrate brain. Philos. Trans. R. Soc. B Biol. Sci. 364,
1005–1020. doi: 10.1098/rstb.2008.0213
Bischoff, S., Leonhard, S., Reymann, N., Schuler, V., Shigemoto, R., Kaupmann,
K., et al. (1999). Spatial distribution of GABABR1 receptor mRNA and binding
sites in the rat brain. J. Comp. Neurol. 412, 1–16. doi: 10.1002/(SICI)1096-
9861(19990913)412:1<1::AID-CNE1>3.3.CO;2-4
Brown, D., Docherty, R., and Halliwell, J. (1983). Chemical transmission in the rat
interpeduncular nucleus in vitro. J. Physiol. 341, 655–670.
Caldecott-Hazard, S., Mazziotta, J., and Phelps, M. (1988). Cerebral correlates of
depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiogra-
phy. J. Neurosci. 8, 1951–1961.
Cappendijk, S. L., and Dzoljic, M. R. (1993). Inhibitory effects of ibogaine
on cocaine self-administration in rats. Eur. J. Pharmacol. 241, 261–265. doi:
10.1016/0014-2999(93)90212-Z
Carlson, J., Noguchi, K., and Ellison, G. (2001). Nicotine produces selective degen-
eration in the medial habenula and fasciculus retroflexus. Brain Res. 906,
127–134. doi: 10.1016/S0006-8993(01)02570-7
Charles, K., Evans, M., Robbins, M., Calver, A., Leslie, R., and Pangalos, M. (2001).
Comparative immunohistochemical localisation of GABA (B1a), GABA (B1b)
and GABA (B2) subunits in rat brain, spinal cord and dorsal root ganglion.
Neuroscience. 106, 447–467. doi: 10.1016/S0306-4522(01)00296-2
Claudio Cuello, A., Emson, P. C., Paxinos, G., and Jessell, T. (1978). Substance
P containing and cholinergic projections from the habenula. Brain Res. 149,
413–429. doi: 10.1016/0006-8993(78)90484-5
Contestabile, A., and Fonnum, F. (1983). Cholinergic and GABAergic forebrain
projections to the habenula and nucleus interpeduncularis: surgical and kainic
acid lesions. Brain Res. 275, 287–297. doi: 10.1016/0006-8993(83)90989-7
Contestabile, A., Villani, L., Fasolo, A., Franzoni, M., Gribaudo, L., Øktedalen,
O., et al. (1987). Topography of cholinergic and substance P pathways in
the habenulo-interpeduncular system of the rat. an immunocytochemical
and microchemical approach. Neuroscience 21, 253–270. doi: 10.1016/0306-
4522(87)90337-X
Cui, C., Booker, T., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., et al.
(2003). The β3 nicotinic receptor subunit: a component of α-conotoxin MII-
binding nicotinic acetylcholine receptors that modulate dopamine release and
related behaviors. J. Neurosci. 23, 11045–11053.
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W.
(2008). From inflammation to sickness and depression: when the immune
system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56. doi: 10.1038/nrn2297
De Biasi, M., and Salas, R. (2008). Influence of neuronal nicotinic receptors
over nicotine addiction and withdrawal. Exp. Biol. Med. 233, 917–929. doi:
10.3181/0712-MR-355
Durkin, M. M., Gunwaldsen, C. A., Borowsky, B., Jones, K. A., and Branchek, T.
A. (1999). An in situ hybridization study of the distribution of the GABA (B2)
Frontiers in Human Neuroscience www.frontiersin.org January 2014 | Volume 7 | Article 931 | 4
Viswanath et al. The medial habenula: still neglected
protein mRNA in the rat CNS.Mol. Brain Res. 71, 185–200. doi: 10.1016/S0169-
328X(99)00182-5
Ellison, G. (1994). Stimulant-induced psychosis, the dopamine theory of
schizophrenia, and the habenula. Brain Res Rev. 19, 223–239. doi: 10.1016/0165-
0173(94)90012-4
Ellison, G. (2002). Neural degeneration following chronic stimulant abuse reveals
a weak link in brain, fasciculus retroflexus, implying the loss of forebrain
control circuitry. Eur. Neuropsychopharmacol. 12, 287–297. doi: 10.1016/S0924-
977X(02)00020-2
Felderhoff-Mueser, U., Schmidt, O. I., Oberholzer, A., Bührer, C., and Stahel, P.
F. (2005). IL-18: a key player in neuroinflammation and neurodegeneration?
Trends Neurosci. 28, 487–493. doi: 10.1016/j.tins.2005.06.008
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., and Kenny, P. J. (2011).
Habenular (agr) 5 nicotinic receptor subunit signalling controls nicotine intake.
Nature 471, 597–601. doi: 10.1038/nature09797
Frahm, S., S´limak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer,
S., et al. (2011). Aversion to nicotine is regulated by the balanced activity of β4
and α5 nicotinic receptor subunits in the medial habenula.Neuron 70, 522–535.
doi: 10.1016/j.neuron.2011.04.013
Franceschini, D., Paylor, R., Broide, R., Salas, R., Bassetto, L., Gotti, C., et al.
(2002). Absence of α7-containing neuronal nicotinic acetylcholine receptors
does not prevent nicotine-induced seizures. Mol. Brain Res. 98, 29–40. doi:
10.1016/S0169-328X(01)00309-6
Geisler, S., Andres, K. H., and Veh, R. W. (2003). Morphologic and cytochemi-
cal criteria for the identification and delineation of individual subnuclei within
the lateral habenular complex of the rat. J. Comp. Neurol. 458, 78–97. doi:
10.1002/cne.10566
Geisler, S., and Trimble, M. (2008). The lateral habenula: no longer neglected. CNS
Spectr. 13, 484–489.
Glick, S. D., Ramirez, R. L., Livi, J. M., and Maisonneuve, I. M. (2006). 18-
methoxycoronaridine acts in the medial habenula and/or interpeduncular
nucleus to decrease morphine self-administration in rats. Eur. J. Pharmacol. 537,
94–98. doi: 10.1016/j.ejphar.2006.03.045
Glick, S., Rossman, K., Steindorf, S., Maisonneuve, I., and Carlson, J. (1991). Effects
and aftereffects of ibogaine on morphine self-administration in rats. Eur. J.
Pharmacol. 195, 341–345. doi: 10.1016/0014-2999(91)90474-5
Gottesfeld, Z. (1983). Origin and distribution of noradrenergic innervation in the
habenula: a neurochemical study. Brain Res. 275, 299–304. doi: 10.1016/0006-
8993(83)90990-3
Groenewegen, H., Ahlenius, S., Haber, S., Kowall, N., and Nauta, W. (1986).
Cytoarchitecture, fiber connections, and some histochemical aspects of the
interpeduncular nucleus in the rat. J. Comp. Neurol. 249, 65–102. doi:
10.1002/cne.902490107
Herkenham, M., and Nauta, W. J. (1977). Afferent connections of the habenular
nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-
passage problem. J. Comp. Neurol. 173, 123–145. doi: 10.1002/cne.901730107
Herkenham, M., and Nauta, W. J. (1979). Efferent connections of the habenular
nuclei in the rat. J. Comp. Neurol. 187, 19–47. doi: 10.1002/cne.901870103
Hokfelt, T., Kellerth, J. O., Nilsson, G., and Pernow, B. (1975). Substance P: local-
ization in the central nervous system and in some primary sensory neurons.
Science 190, 889–890. doi: 10.1126/science.242075
Jhou, T. C., Geisler, S., Marinelli, M., DeGarmo, B. A., and Zahm, D. S. (2009a).
The mesopontine rostromedial tegmental nucleus: a structure targeted by
the lateral habenula that projects to the ventral tegmental area of tsai and
substantia nigra compacta. J. Comp. Neurol. 513, 566–596. doi: 10.1002/cne.
21891
Jhou, T. C., Fields, H. L., Baxter, M. G., Saper, C. B., and Holland, P.
C. (2009b). The rostromedial tegmental nucleus (RMTg), a GABAergic
afferent to midbrain dopamine neurons, encodes aversive stimuli and
inhibits motor responses. Neuron 61, 786–800. doi: 10.1016/j.neuron.
2009.02.001
Kedmi, M., Beaudet, A. L., and Orr-Urtreger, A. (2004). Mice lacking neuronal
nicotinic acetylcholine receptor β4-subunit and mice lacking both α5-and β4-
subunits are highly resistant to nicotine-induced seizures. Physiol. Genom. 17,
221–229. doi: 10.1152/physiolgenomics.00202.2003
Kelly, P. H. (1998). Defective inhibition of dream event memory
formation: a hypothesized mechanism in the onset and progres-
sion of symptoms of schizophrenia. Brain Res. Bull. 46, 189–197. doi:
10.1016/S0361-9230(98)00011-2
Kim, U., and Chang, S. (2005). Dendritic morphology, local circuitry, and intrinsic
electrophysiology of neurons in the rat medial and lateral habenular nuclei of
the epithalamus. J. Comp. Neurol. 483, 236–250. doi: 10.1002/cne.20410
Kobayashi, Y., Sano, Y., Vannoni, E., Goto, H., Suzuki, H., Oba, A., et al. (2013).
Genetic dissection of medial habenula–interpeduncular nucleus pathway func-
tion in mice. Front. Behav. Neurosci. 7:17. doi: 10.3389/fnbeh.2013.00017
Kubota, T., Fang, J., Brown, R. A., and Krueger, J. M. (2001). Interleukin-18 pro-
motes sleep in rabbits and rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281,
R828–R838.
Lecourtier, L., and Kelly, P. H. (2007). A conductor hidden in the orches-
tra? Role of the habenular complex in monoamine transmission and cog-
nition. Neurosci. Biobehav. Rev. 31, 658–672. doi: 10.1016/j.neubiorev.2007.
01.004
Lecourtier, L., Neijt, H. C., and Kelly, P. H. (2004). Habenula lesions cause impaired
cognitive performance in rats: implications for schizophrenia. Eur. J. Neurosci.
19, 2551–2560. doi: 10.1111/j.0953-816X.2004.03356.x
Lee, A., Mathuru, A. S., Teh, C., Kibat, C., Korzh, V., Penney, T. B., et al. (2010).
The habenula prevents helpless behavior in larval zebrafish. Curr. Biol. 20,
2211–2216. doi: 10.1016/j.cub.2010.11.025
Lee, Y., and Goto, Y. (2011). Neurodevelopmental disruption of cortico-striatal
function caused by degeneration of habenula neurons. PLoS ONE 6:e19450. doi:
10.1371/journal.pone.0019450
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., et al.
(2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature
445, 168–176. doi: 10.1038/nature05453
Li, B., Piriz, J., Mirrione, M., Chung, C., Proulx, C. D., Schulz, D., et al. (2011).
Synaptic potentiation onto habenula neurons in the learned helplessness model
of depression. Nature 470, 535–539. doi: 10.1038/nature09742
Maskos, U., Molles, B., Pons, S., Besson, M., Guiard, B., Guilloux, J., et al.
(2005). Nicotine reinforcement and cognition restored by targeted expression
of nicotinic receptors. Nature 436, 103–107. doi: 10.1038/nature03694
Mathuru, A. S., and Jesuthasan, S. (2013). The medial habenula as a reg-
ulator of anxiety in adult zebrafish. Front. Neural Circuits 7:99. doi:
10.3389/fncir.2013.00099
Matsumoto, M., and Hikosaka, O. (2007). Lateral habenula as a source of
negative reward signals in dopamine neurons. Nature 447, 1111–1115. doi:
10.1038/nature05860
Matsumoto,M., andHikosaka, O. (2009). Two types of dopamine neuron distinctly
convey positive and negative motivational signals. Nature 459, 837–841. doi:
10.1038/nature08028
McCallum, S. E., Cowe, M. A., Lewis, S. W., and Glick, S. D. (2012). α3β4
nicotinic acetylcholine receptors in the medial habenula modulate the mesolim-
bic dopaminergic response to acute nicotine in vivo. Neuropharmacology 63,
434–440. doi: 10.1016/j.neuropharm.2012.04.015
McCormick, D. A., and Prince, D. A. (1987). Actions of acetylcholine in the guinea-
pig and cat medial and lateral geniculate nuclei, in vitro. J. Physiol. 392, 147–165.
McGehee, D. S., Heath, M., Gelber, S., Devay, P., and Role, L. W. (1995). Nicotine
enhancement of fast excitatory synaptic transmission in CNS by presynaptic
receptors. Science 269, 1692–1696. doi: 10.1126/science.7569895
Nisell, M., Nomikos, G. G., and Svensson, T. H. (1994). Infusion of nicotine
in the ventral tegmental area or the nucleus accumbens of the rat differen-
tially affects accumbal dopamine release. Pharmacol. Toxicol. 75, 348–352. doi:
10.1111/j.1600-0773.1994.tb00373.x
Phillipson, O., and Pycock, C. (1982). Dopamine neurones of the ventral
tegmentum project to both medial and lateral habenula. Exp. Brain Res. 45,
89–94.
Picciotto, M. R., and Corrigall, W. A. (2002). Neuronal systems underlying behav-
iors related to nicotine addiction: neural circuits and molecular genetics.
J. Neurosci. 22, 3338–3341.
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M.,
et al. (1998). Acetylcholine receptors containing the β2 subunit are involved in
the reinforcing properties of nicotine. Nature 391, 173–177. doi: 10.1038/34413
Qin, C., and Luo, M. (2009). Neurochemical phenotypes of the afferent and effer-
ent projections of the mouse medial habenula. Neuroscience 161, 827–837. doi:
10.1016/j.neuroscience.2009.03.085
Quick, M. W., Ceballos, R. M., Kasten, M., McIntosh, J. M., and Lester,
R. A. (1999). α3β4 subunit-containing nicotinic receptors dominate func-
tion in rat medial habenula neurons. Neuropharmacology 38, 769–783. doi:
10.1016/S0028-3908(99)00024-6
Frontiers in Human Neuroscience www.frontiersin.org January 2014 | Volume 7 | Article 931 | 5
Viswanath et al. The medial habenula: still neglected
Ren, J., Qin, C., Hu, F., Tan, J., Qiu, L., Zhao, S., et al. (2011). Habenula
“cholinergic” neurons corelease glutamate and acetylcholine and activate post-
synaptic neurons via distinct transmission modes. Neuron 69, 445–452. doi:
10.1016/j.neuron.2010.12.038
Rezvani, A. H., Overstreet, D., and Leef, Y. (1995). Attenuation of alcohol intake by
ibogaine in three strains of alcohol-preferring rats. Pharmacol. Biochem. Behav.
52, 615–620. doi: 10.1016/0091-3057(95)00152-M
Rønnekleiv, O., andMøller, M. (1979). Brain-pineal nervous connections in the rat:
an ultrastructure study following habenular lesion. Exp. Brain Res. 37, 551–562.
doi: 10.1007/BF00236823
Salas, R., Baldwin, P., De Biasi, M., and Montague, P. R. (2010). BOLD Responses
to negative reward prediction errors in human habenula. Front. Hum. Neurosci.
4:36. doi: 10.3389/fnhum.2010.00036
Salas, R., Pieri, F., and De Biasi, M. (2004a). Decreased signs of nicotine withdrawal
in mice null for the β4 nicotinic acetylcholine receptor subunit. J. Neurosci. 24,
10035–10039. doi: 10.1523/JNEUROSCI.1939-04.2004
Salas, R., Cook, K. D., Bassetto, L., and De Biasi, M. (2004b). The α3 and β4
nicotinic acetylcholine receptor subunits are necessary for nicotine-induced
seizures and hypolocomotion in mice. Neuropharmacology 47, 401–407. doi:
10.1016/j.neuropharm.2004.05.002
Salas, R., Pieri, F., Fung, B., Dani, J. A., and De Biasi, M. (2003). Altered anxiety-
related responses in mutant mice lacking the β4 subunit of the nicotinic
receptor. J. Neurosci. 23, 6255–6263.
Salas, R., Sturm, R., Boulter, J., and De Biasi, M. (2009). Nicotinic receptors in
the habenulo-interpeduncular system are necessary for nicotine withdrawal in
mice. J. Neurosci. 29, 3014–3018. doi: 10.1523/JNEUROSCI.4934-08.2009
Sandyk, R. (1991). Relevance of the habenular complex to neuropsy-
chiatry: a review and hypothesis. Int. J. Neurosci. 61, 189–219. doi:
10.3109/00207459108990738
Sartorius, A., Kiening, K. L., Kirsch, P., von, Gall, C. C., Haberkorn, U., Unterberg,
A. W., et al. (2010). Remission of major depression under deep brain stimula-
tion of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 67,
e9–e11. doi: 10.1016/j.biopsych.2009.08.027
Savitz, J. B., Nugent, A. C., Bogers, W., Roiser, J. P., Bain, E. E., Neumeister, A.,
et al. (2011). Habenula volume in bipolar disorder and major depressive dis-
order: a high-resolution magnetic resonance imaging study. Biol. Psychiatry 69,
336–343. doi: 10.1016/j.biopsych.2010.09.027
Sheffield, E. B., Quick, M. W., and Lester, R. A. (2000). Nicotinic acetyl-
choline receptor subunit mRNA expression and channel function in medial
habenula neurons. Neuropharmacology 39, 2591–2603. doi: 10.1016/S0028-
3908(00)00138-6
Shumake, J., Edwards, E., and Gonzalez-Lima, F. (2003). Opposite metabolic
changes in the habenula and ventral tegmental area of a genetic model of help-
less behavior. Brain Res. 963, 274–281. doi: 10.1016/S0006-8993(02)04048-9
Sperlagh, B., Magloczky, Z., Vizi, E., and Freund, T. (1998). The triangular septal
nucleus as the major source of ATP release in the rat habenula: a combined
neurochemical and morphological study. Neuroscience 86, 1195–1207. doi:
10.1016/S0306-4522(98)00026-8
Strecker, R. E., and Rosengren, E. (1989). Regulation of striatal serotonin release
by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by
in vivo microdialysis: role of excitatory amino acids and GABA. Brain Res. 492,
187–202. doi: 10.1016/0006-8993(89)90901-3
Strotmann, B., Koegler, C., and Weiss, M. (2013a). “Internal structure of human
habenula with ex vivo MRI at 7T,” in Poster Presented at OHBM (Seattle, WA).
Strotmann, B., Heidemann, R., Trampel, R., Villringer, A., and Turner, R. (2013b).
“High-resolution fMRI of the human habenula at 7T,” in Poster Presented at
OHBM (Seattle, WA).
Sugama, S., Cho, B. P., Baker, H., Joh, T. H., Lucero, J., and Conti, B. (2002).
Neurons of the superior nucleus of the medial habenula and ependymal
cells express IL-18 in rat CNS. Brain Res. 958, 1–9. doi: 10.1016/S0006-
8993(02)03363-2
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca,
C., et al. (2004). Nicotine activation of α4∗ receptors: sufficient for reward,
tolerance, and sensitization. Science 306, 1029–1032. doi: 10.1126/science.
1099420
Taraschenko, O. D., Shulan, J. M., Maisonneuve, I. M., and Glick, S. D. (2007).
18-MC acts in the medial habenula and interpeduncular nucleus to attenu-
ate dopamine sensitization to morphine in the nucleus accumbens. Synapse 61,
547–560. doi: 10.1002/syn.20396
Ullsperger, M., and von Cramon, D. Y. (2003). Error monitoring using exter-
nal feedback: specific roles of the habenular complex, the reward system, and
the cingulate motor area revealed by functional magnetic resonance imaging.
J. Neurosci. 23, 4308–4314.
Wang, D., Gong, N., Luo, B., and Xu, T. (2006). Absence of GABA type A sig-
naling in adult medial habenular neurons. Neuroscience 141, 133–141. doi:
10.1016/j.neuroscience.2006.03.045
Xu, W., Gelber, S., Orr-Urtreger, A., Armstrong, D., Lewis, R. A., Ou, C., et al.
(1999a). Megacystis, mydriasis, and ion channel defect in mice lacking the
α3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 96,
5746–5751. doi: 10.1073/pnas.96.10.5746
Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutcliffe, C. B., Armstrong, D.,
et al. (1999b). Multiorgan autonomic dysfunction in mice lacking the β2 and
the β4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 19,
9298–9305.
Yamaguchi, T., Danjo, T., Pastan, I., Hikida, T., and Nakanishi, S. (2013). Distinct
roles of segregated transmission of the septo-habenular pathway in anxiety and
fear. Neuron. 78, 537–544. doi: 10.1016/j.neuron
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 25 October 2013; paper pending published: 20 November 2013; accepted: 22
December 2013; published online: 17 January 2014.
Citation: Viswanath H, Carter AQ, Baldwin PR, Molfese DL and Salas R (2014) The
medial habenula: still neglected. Front. Hum. Neurosci. 7:931. doi: 10.3389/fnhum.
2013.00931
This article was submitted to the journal Frontiers in Human Neuroscience.
Copyright © 2014 Viswanath, Carter, Baldwin, Molfese and Salas. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Human Neuroscience www.frontiersin.org January 2014 | Volume 7 | Article 931 | 6
